Search
Medline Ord Shs Class A
MDLNAdd to Watchlist
39.760USD
-0.590-1.46%
Close 11-05 16:00（ET）
52.27BMarket Cap
33.54P/E TTM
Medline Ord Shs Class A (MDLN) Stock Price Target & Forecast
Analyst Rating
Based on 28 analysts
Buy
10 Strong Buy
12 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
44.320USD+37.98%
MDLN Analyst Recommendation Trends
In the current month, MDLN has received 12 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. MDLN average Analyst price target in the last month is 44.320.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
10
10
10
10
10
10
10
10
12
12
12
13
13
12
12
13
6
6
6
6
6
6
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
28
28
29
29
28
27
28
MDLN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Dexcom Inc
DXCM
13
12
4
0
0
29
Abbott Laboratories
ABT
11
13
4
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Alcon AG
ALC
6
9
3
1
0
19
Financial Forecasting
Based on analysts' estimates, MDLN EPS is projected to reach 0.401 in FY2026Q4, following reported EPS of 0.223 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.30
0.32
0.35
0.40
0.34
Actual
0.16
0.07
0.22
--
--
Surprise
-45.46%
-78.63%
-36.06%
--
--
FAQs
What is Medline Ord Shs Class A's expected revenue for the next quarter?
Medline Ord Shs Class A's expected revenue is 8.48B.
What is Medline Ord Shs Class A's price target?
Analysts forecast that Medline Ord Shs Class A's price target is USD 44.32, with the highest forecast at USD 55.00 and the lowest forecast at USD 34.00.
How have Medline Ord Shs Class AMDLN's recent earnings per share performed?
The market expectation was USD 0.22, while Medline Ord Shs Class AMDLN's earnings per share (EPS) for the previous quarter was USD 0.07. EPS for the next quarter is expected at USD 0.40.
What is the analyst rating for Medline Ord Shs Class A?
Based on the ratings of Medline Ord Shs Class A's stock from 28 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.